http://www.maniacsolutions.com/direct-marketing-statistics/
Prolific (R) (Denosumab) has granted Marketing Authorisation in the European Union Thousand Oaks, California, May 28, 2010 (ots / PRNewswire) – Amgen Inc. announced today that the European Commission (EC) has granted permission to proliferate (R) (denosumab) for the treatment of osteoporosis in postmenopausal women with …
DMA07 Conference & Exhibition